Tania LaGambinaMay 152 minRosa Biotech accelerates NASH pre-clinical trial in liver diseaseBio-sensing pioneer secures £415,000 from angel investors Funding will accelerate non-alcoholic fatty liver disease (NAFLD / NASH)...
Arne ScottMar 272 minRosa publishes founding research in Nature CommunicationsWe are delighted to publish the founding research behind Rosa and our Pandra platform in Nature Communications. The paper - a...